Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Age-related macular degeneration (AMD) is a disease that blurs the sharp, central vision you need for “straight-ahead” activities such as reading, sewing, and driving. AMD affects the macula, the part of the eye that allows you to see fine detail.
Age Related Macular Degeneration Drug is widely used in hospitals, clinics and other field. The most proportion of Age Related Macular Degeneration Drug is used in Hospital, and the proportion in 2017 is 72%.
North America is the largest consumption place, with a consumption market share nearly 65.6% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 30%.
The global Age Related Macular Degeneration Drug market is valued at 6080 million US$ in 2018 and will reach 9620 million US$ by the end of 2025, growing at a CAGR of 5.9% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Age Related Macular Degeneration Drug market based on company, product type, end user and key regions.
This report studies the global market size of Age Related Macular Degeneration Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Age Related Macular Degeneration Drug in these regions.
This research report categorizes the global Age Related Macular Degeneration Drug market by top players/brands, region, type and end user. This report also studies the global Age Related Macular Degeneration Drug market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Regeneron Pharmaceuticals
Bayer HealthCare
Novartis
Roche
Kanghong Pharma
Market size by Product
Lucentis
Eylea
Avastin
Other
Market size by End User
Hospitals
Clinics
Other
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Age Related Macular Degeneration Drug market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Age Related Macular Degeneration Drug market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Age Related Macular Degeneration Drug companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Age Related Macular Degeneration Drug submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Age Related Macular Degeneration Drug are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Age Related Macular Degeneration Drug market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Age Related Macular Degeneration Drug is widely used in hospitals, clinics and other field. The most proportion of Age Related Macular Degeneration Drug is used in Hospital, and the proportion in 2017 is 72%.
North America is the largest consumption place, with a consumption market share nearly 65.6% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 30%.
The global Age Related Macular Degeneration Drug market is valued at 6080 million US$ in 2018 and will reach 9620 million US$ by the end of 2025, growing at a CAGR of 5.9% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Age Related Macular Degeneration Drug market based on company, product type, end user and key regions.
This report studies the global market size of Age Related Macular Degeneration Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Age Related Macular Degeneration Drug in these regions.
This research report categorizes the global Age Related Macular Degeneration Drug market by top players/brands, region, type and end user. This report also studies the global Age Related Macular Degeneration Drug market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Regeneron Pharmaceuticals
Bayer HealthCare
Novartis
Roche
Kanghong Pharma
Market size by Product
Lucentis
Eylea
Avastin
Other
Market size by End User
Hospitals
Clinics
Other
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Age Related Macular Degeneration Drug market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Age Related Macular Degeneration Drug market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Age Related Macular Degeneration Drug companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Age Related Macular Degeneration Drug submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Age Related Macular Degeneration Drug are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Age Related Macular Degeneration Drug market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
